From: Prognostic significance of lymphangiogenesis in pharyngolaryngeal carcinoma patients
Clinicopathologic feature | N° cases (%) |
---|---|
Age | Mean 60 (33-86) |
Sex | |
Male | 98 (94.2) |
Female | 6 (5.8) |
Tumour site | |
Hypopharynx | 18 (17.5) |
Oropharynx | 31 (30.1) |
Glottis | 30 (29.1) |
Supraglottis | 24 (23.3) |
T category | |
1 | 19 (18.3) |
2 | 20 (19.2) |
3 | 30 (28.9) |
4 | 35 (33.6) |
N category | |
0 | 47 (45.2) |
1 | 8 (7.7) |
2 | 41 (39.4) |
3 | 8 (7.7) |
Degree of differentiation | |
Well | 48 (49) |
Moderate | 32 (32.6) |
Poor | 18 (18.4) |
Tumour stage (TNM a ) | |
I | 18 (18.18) |
II | 10 (10.10) |
III | 14 (14.14) |
IV | 57 (57.58) |
Status | |
Alive without tumour | 49 (47) |
Alive with tumour | 3 (3) |
Death of tumour | 34 (33) |
Death other causes | 18 (17) |
Recurrence | |
No | 66 (66) |
Yes | 34 (34) |
Toxic habits | |
Cigarette smoking | 103 (99) |
Alcohol consumption | 91 (88) |
Mean follow up (months) (range) | |
Whole population | 23 (10 - 67) |
Larynx | 26 (9 - 67) |
Pharynx | 20 (10 - 66) |